{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:37Z","timestamp":1786984237281,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The diverse pathogenic mechanisms of myocardial infarction with nonobstructive coronary artery disease (MINOCA) result in therapeutic difficulties. The purpose of this meta-analysis was to assess the impact of dual antiplatelet therapy (DAPT) on prognosis of patients with MINOCA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Relevant studies published prior to May 2025 were identified through a search of the PubMed, Embase and Web of Science databases. We evaluated the data using hazard ratios (HRs) and 95% confidence interval (CI). Heterogeneity among studies was assessed by\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      and Cochran\u2019s\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      test. To identify the sources of heterogeneity, subgroup analysis was conducted according to the predefined criteria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Six studies enrolling 13,027 patients with MINOCA were pooled in the meta-analysis. After 48 months of follow-up, DAPT showed no significant association with a reduced risk of major adverse cardiovascular events (HR\u2005=\u20051.00; 95% CI, 0.71\u20131.41;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.985). Aggregate data from 4 studies indicated that DAPT was associated with a significant reduction of all-cause death (HR\u2005=\u20050.76; 95% CI, 0.60\u20130.96;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.021). However, results from 3 studies regarding myocardial infarction were not statistically significant (HR\u2005=\u20051.03; 95% CI, 0.72\u20131.45;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.885).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings suggest that while DAPT offers a survival benefit for MINOCA patients, it does not reduce the risk of major adverse cardiovascular events and myocardial infarction. Further large randomized controlled trials are required to evaluate individual treatment based on the different etiologies of MINOCA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050222","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:01:14Z","timestamp":1786730474000},"page":"e50222","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effect of dual antiplatelet therapy on prognosis of patients with myocardial infarction with nonobstructive coronary artery disease"],"prefix":"10.1097","volume":"105","author":[{"given":"Yao","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lei","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9967-0164","authenticated-orcid":false,"given":"Xiao-Qing","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2796.2012.02591.x","article-title":"Assessing patients with myocardial infarction and nonobstructed coronary arteries (MINOCA).","volume":"273","author":"Beltrame","year":"2013","journal-title":"J Intern Med"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.3390\/jcm12196198","article-title":"Diagnostic puzzles and cause-targeted treatment strategies in myocardial infarction with non-obstructive coronary arteries: an updated review.","volume":"12","author":"Samaras","year":"2023","journal-title":"J Clin Med"},{"key":"R3-20260817","first-page":"813","article-title":"Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA).","volume":"10","author":"Occhipinti","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ahj.2018.03.005","article-title":"Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries.","volume":"200","author":"Hjort","year":"2018","journal-title":"Am Heart J"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"e004185","DOI":"10.1161\/JAHA.116.004185","article-title":"Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome: a meta-analysis.","volume":"5","author":"Pizzi","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.hlc.2017.02.023","article-title":"Myocardial infarction without obstructive coronary artery disease is not a benign condition (ANZACS-QI 10).","volume":"27","author":"Barr","year":"2018","journal-title":"Heart Lung Circ"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"47","DOI":"10.31083\/j.rcm2502047","article-title":"A personalized approach for patients with myocardial infarction with non-obstructive coronary arteries.","volume":"25","author":"De Luca","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"R8-20260817","first-page":"942","article-title":"Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): current insights into pathophysiology, diagnosis, and management.","volume":"15","author":"Tognola","year":"2025","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/heartjnl-2024-324565","article-title":"Pathological findings at invasive assessment in MINOCA: a systematic review and meta-analysis.","volume":"111","author":"Fedele","year":"2025","journal-title":"Heart"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.recesp.2021.07.017","article-title":"Impact of lipid-lowering therapies on cardiovascular outcomes according to coronary artery calcium score. A systematic review and meta-analysis.","volume":"75","author":"Gallone","year":"2022","journal-title":"Rev Espanola Cardiol"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3389\/fphar.2019.01606","article-title":"Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease.","volume":"10","author":"Paolisso","year":"2019","journal-title":"Front Pharmacol"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease.","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MCA.0000000000001323","article-title":"Long-term outcomes in very young patients with myocardial infarction with non-obstructive coronary arteries.","volume":"35","author":"Ipek","year":"2024","journal-title":"Coron Artery Dis"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"807494","DOI":"10.3389\/fcvm.2021.807494","article-title":"Real-world use of clopidogrel and ticagrelor in patients with myocardial infarction with nonobstructive coronary arteries: patient characteristics and long-term outcomes.","volume":"8","author":"Gao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2020.11.040","article-title":"Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): insights from a multicentre national registry.","volume":"327","author":"Ciliberti","year":"2021","journal-title":"Int J Cardiol"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/heartjnl-2020-318045","article-title":"Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.","volume":"107","author":"Bossard","year":"2021","journal-title":"Heart"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00380-021-01956-2","article-title":"Comparing pharmacotherapy in MINOCA versus medically managed obstructive acute coronary syndrome.","volume":"37","author":"Adams","year":"2022","journal-title":"Heart Vessels"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.08.034","article-title":"Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with Non-Obstructive Coronary Artery disease (MINOCA): a meta-analysis.","volume":"368","author":"De Filippo","year":"2022","journal-title":"Int J Cardiol"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/HCO.0000000000000886","article-title":"Myocardial infarction with nonobstructive coronary artery disease (MINOCA): a review of pathophysiology and management.","volume":"36","author":"Cheema","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.120.052008","article-title":"Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women.","volume":"143","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jcmg.2022.10.023","article-title":"Clinical characteristics and prognosis of MINOCA caused by atherosclerotic and nonatherosclerotic mechanisms assessed by OCT.","volume":"16","author":"Zeng","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/jcm12062129","article-title":"Role of intracoronary imaging in Myocardial Infarction with Non-Obstructive Coronary Disease (MINOCA): a review.","volume":"12","author":"Borzillo","year":"2023","journal-title":"J Clin Med"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"e005860","DOI":"10.1161\/CIRCINTERVENTIONS.117.005860","article-title":"EROSION study (effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion): a 1-year follow-up report.","volume":"10","author":"Xing","year":"2017","journal-title":"Cir Cardiovasc Interv"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"1081934","DOI":"10.3389\/fcvm.2022.1081934","article-title":"Antiplatelet therapy in patients with myocardial infarction with non-obstructive coronary arteries: a clinical perspective.","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R26-20260817","doi-asserted-by":"crossref","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","article-title":"Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association.","volume":"139","author":"Tamis-Holland","year":"2019","journal-title":"Circulation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:00:21Z","timestamp":1786982421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050222"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":26,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050222","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2025-08-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}